In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to ESC Professional Members, Fellows of the ESC, and Young combined Members

Coronary vasomotor abnormalities in women with angina pectoris and unobstructed coronary arteries are associated with a positive family history

Session Poster session 1

Speaker Peter Emanuel Ong

Event : ESC Congress 2017

  • Topic : coronary artery disease, acute coronary syndromes, acute cardiac care
  • Sub-topic : Coronary Artery Disease (Chronic)
  • Session type : Poster Session

Authors : P E Ong (Stuttgart,DE), G Pirozzolo (Stuttgart,DE), A Athanasiadis (Stuttgart,DE), U Sechtem (Stuttgart,DE)

Authors:
P.E. Ong1 , G. Pirozzolo1 , A. Athanasiadis1 , U. Sechtem1 , 1Robert Bosch Hospital - Stuttgart - Germany ,

Citation:
European Heart Journal ( 2017 ) 38 ( Supplement ), 186

Background: Approximately 50% of patients with angina pectoris undergoing coronary angiography have unobstructed coronary arteries. Coronary vasomotor abnormalities (coronary spasm, microvascular dysfunction) can be diagnosed using intracoronary acetylcholine testing in approx. 60% of such cases. Women are more prone to this scenario than men but the underlying causes are still not properly understood. Genetic polymorphisms for coronary vasomotor disorders have not yet been investigated/identified in European patients systematically. However, frequently a positive family history is found in these patients.

Purpose: The aim of this study was to assess whether a positive family history for cardiovascular disease is significantly more often found in patients with coronary vasomotor disorders.

Methods: Over a period of 3 years a total number of 415 consecutive patients (mean age 62±10 years, 62% female) with stable angina and unobstructed coronary arteries (no stenosis >50%) was recruited. All patients underwent intracoronary acetylcholine testing (ACh-test) according to a standardised protocol. The ACh-test revealed epicardial coronary spasm in 33% and coronary microvascular dysfunction in 30% of patients. In the remaining 37% no relevant coronary vasomotor disorder could be found. The following cardiovascular risk factors were systematically analysed: hypertension, hypercholesterolemia, diabetes mellitus, active cigarette smoking and a positive family history for cardiovascular disease. The latter was defined as a first degree relative with myocardial infarction or stroke.

Results: Women were more likely to have an abnormal ACh-test than men (72% vs. 49%, p<0.0005) and women with an abnormal ACh-test had significantly more often a microvascular than epicardial disorder (57% vs. 43%, p<0.0005). In contrast, male patients with abnormal ACh-test had more often an epicardial than a microvascular disorder (74% vs. 26%, p<0.0005). A positive family history was found in 55% of all patients with a significant preponderance among women compared to men (p=0.001, 61% vs. 45%). Moreover, among the patients with epicardial spasm, women had significantly more often a positive family history compared to men (p=0.006, 66% vs. 42%).

Conclusion: Patients with angina pectoris and unobstructed coronary arteries are often female and frequently suffer from a coronary vasomotor disorder diagnosed by acetylcholine testing. Epicardial coronary spasm in women is linked with a positive family history pointing towards a genetic background of this disease.

The free consultation period for this content is over.

It is now only available year-round to ESC Professional Members, Fellows of the ESC, and Young combined Members

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are